4.7 Article

Immunotherapy with IL-10-and IFN-γ-producing CD4 effector cells modulate Natural and Inducible CD4 TReg cell subpopulation levels: observations in four cases of patients with ovarian cancer

期刊

CANCER IMMUNOLOGY IMMUNOTHERAPY
卷 61, 期 6, 页码 839-854

出版社

SPRINGER
DOI: 10.1007/s00262-011-1128-x

关键词

Tumor immunity; Regulatory T cells; Th1 effector cells; TNF superfamily; T effector/memory cells; Adoptive T cell immunotherapy; IL-10; IFN-gamma; Recurrent ovarian cancer

资金

  1. Harrington Cancer Research Foundation, Amarillo, TX
  2. Department of Veterans Affairs
  3. Texas Tech School of Medicine
  4. National Institutes of Health [1R21CA89883-01A1]
  5. Department of Defense Medical Research Development Command DAMD [17-01-1-0429]
  6. Don & Sybil Harrington Foundation, Amarillo, TX

向作者/读者索取更多资源

Adoptive T cell therapy for cancer patients optimally requires participation of CD4 T cells. In this phase I/II study, we assessed the therapeutic effects of adoptively transferred IL-10- and IFN-gamma-producing CD4 effector cells in patients with recurrent ovarian cancer. Using MUC1 peptide and IL-2 for ex vivo CD4 effector cell generation, we show that three monthly treatment cycles of autologous T cell restimulation and local intraperitoneal re-infusion-modulated T cell-mediated immune responses that were associated with enhanced patient survival. One patient remains disease-free, another patient experienced prolonged survival for nearly 16 months with recurrent disease, and two patients expired within 3-5 months following final infusion. Prolonged survivors showed elevated levels of systemic CD3(+)CD4(+)CD25(+) and CD3(+)CD4(+)CD25(-) T cells when compared to that of pre-treatment levels and similarly treated short-term survivors. Such cell populations among these patients contained variable levels of Inducible Tr1 (CD4(+)CD25(-)FoxP3(-)IL-10(+)) and Natural (CD4(+)CD25(+)CD45RO(+)FoxP3(+)) TReg cell numbers and ratios that were associated with prolonged and/or disease-free survival. Moreover, peptide-restimulated T cells from these patients showed an elevation in both IFN-gamma production, memory cell phenotype, and select TNF family ligands associated with enhanced T cell survival and apoptosis-inducing activities. This suggests that intraperitoneally administered Th1-like cells, producing elevated levels of IL-10, may require and/or induce differential levels of distinct systemic TReg subpopulations that influence, in part, long-term tumor immunity and enhanced memory/effector CD4-mediated therapeutic potentials. Furthermore, treatment efficacy and enhanced memory cell phenotype did not appear to be dependent on TReg cell numbers but upon ratios of Inducible and Natural TReg subpopulations.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据